Tag Archives: Health

Feds Threaten to Pull ProAmatine for Lack of Postmarket Data (Updated 8/18)

By George Koroneos | Published: August 16, 2010
Image via Wikipedia FDA on Monday announced that it was looking to withdraw approval for the low-blood-pressure treatment midodrine hydrochloride because the companies manufacturing the drug failed to provide data from post-approval studies. The kicker: The drug was approved 14 years ago. FDA gave midodrine hydrochloride—branded by Shire as ProAmatine and produced by a half-dozen generics firms—the green [...]
Posted in FDA | Also tagged , , , , , , , | Leave a comment

Alzheimer’s Test Offers Early Diagnosis

By George Koroneos | Published: August 11, 2010
Image via Wikipedia A research team in Belgium discovered a new test that has proven successful at identifying patients that are developing Alzheimer’s disease, according to a report published in the Archives of Neurology on Tuesday. The study took spinal fluid from patients with varying levels of cognitive memory and looked for a specific protein signature or [...]
Posted in R&D, Technology | Also tagged , , , , , , | Leave a comment

Study: Future of Personalized Medicine

By Jeff Schindler | Published: July 27, 2010
An increased focus on targeted medicine has become a staple for all facets of healthcare, from drug developers to consumers to pharma companies. Gerson Lehrman and Bloomberg jointly commissioned a survey that gauged the reactions and predictions of this trend from 52 leading US physicians. The survey covered a number of topics to assess which [...]
Posted in R&D | Also tagged , , , , , , | 1 Comment

Weight-Loss Drug Qnexa Loses in FDA Committee Ruling

By Jeff Schindler | Published: July 16, 2010
Vivus’ Qnexa may help in weight loss, but it also now risks losing its place in the market following FDA’s Advisory Committee’s ruling July 15. The panel of medical experts did not question the effectiveness of the drug, but rather voiced its concerns over safety of the medication. The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee [...]
Posted in FDA, Safety | Also tagged , , , , , , | 1 Comment

Unbranded Pharma Sites Gain Traction

By George Koroneos | Published: May 11, 2010
Image by alles-schlumpf via Flickr The popularity of unbranded pharma Web sites amongst consumers appears to be on an up tick, according to new data released by Manhattan Research this week. The report, “Unbranded Web sites: Brand Reach throughout the Patient Life Cycle” looked at how many consumers actively use unbranded pharma sites and to what degree [...]
Posted in Marketing | Also tagged , , , , , , | Leave a comment